These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2480025)

  • 21. Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera.
    Schneider T; Harthus HP; Hildebrandt P; Niedrig M; Bröker M; Weigelt W; Beck A; Pauli G
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):37-44. PubMed ID: 1707640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-idiotypic antisera raised against monoclonal antibody specific for a p24 gag region epitope detects a common interspecies idiotype associated with anti-HIV responses.
    Morrow WJ; Gaston I; Anderson T; Haigwood N; McGrath MS; Rosen J; Steimer KS
    Viral Immunol; 1990; 3(2):99-109. PubMed ID: 1694432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human monoclonal antibodies to HIV-1: cross-reactions with gag and env products.
    Pollock BJ; McKenzie AS; Kemp BE; McPhee DA; D'Apice AJ
    Clin Exp Immunol; 1989 Dec; 78(3):323-8. PubMed ID: 2482145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of monoclonal antibodies against the p17 core protein of the human immunodeficiency virus 1.
    Cogniaux J; De Schepper N; Blondiau ML; Cornet B; Horal P; Vahlne A
    J Immunol Methods; 1990 Apr; 128(2):165-75. PubMed ID: 1691236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-env and anti-gag antibodies in subjects infected with the human immunodeficiency virus].
    Sanz del Forcallo FJ; García Delgado R; Ortiz Maslloréns F
    Rev Clin Esp; 1989 Dec; 185(9):443-7. PubMed ID: 2696006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
    Marsac D; Puaux AL; Rivière Y; Michel ML
    Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping.
    Papsidero LD; Sheu M; Ruscetti FW
    J Virol; 1989 Jan; 63(1):267-72. PubMed ID: 2462060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibodies against avian reticuloendotheliosis virus: identification of strain-specific and strain-common epitopes.
    Cui ZZ; Lee LF; Silva RF; Witter RL
    J Immunol; 1986 Jun; 136(11):4237-42. PubMed ID: 2422277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell.
    Ota A; Liu X; Fujio H; Sakato N; Ueda S
    Hybridoma; 1998 Feb; 17(1):73-5. PubMed ID: 9523241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of antigenic structure of HIV-1 protein p24 using monoclonal antibodies].
    Konovalov EE; Loktev VB; Pokrovskiĭ AG; Fediuk NV; Chernykh AI; Nechaev IuS; Kuliandin SA; Kipriianov SM; Ofitserov VI
    Vestn Ross Akad Med Nauk; 1992; (9-10):55-9. PubMed ID: 1283723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of monoclonal antibodies to human immunodeficiency virus type 2 envelope glycoproteins.
    Traincard F; Rey-Cuillé MA; Huon I; Dartevelle S; Mazié JC; Benichou S
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1659-67. PubMed ID: 7888225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV experimental vaccines based on the iscom technology using envelope and GAG gene products.
    Akerblom L; Nara P; Dunlop N; Putney S; Morein B
    Biotechnol Ther; 1993; 4(3-4):145-61. PubMed ID: 8292967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic domains of the HIV-1 vif protein as recognized by human sera and murine monoclonal antibodies.
    Wieland U; Kratschmann H; Kehm R; Kühn JE; Näher H; Kramer MD; Braun RW
    AIDS Res Hum Retroviruses; 1991 Nov; 7(11):861-7. PubMed ID: 1760226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of large glycosylated proteins recognized by monoclonal antibodies against HIV-1 gag proteins.
    Pinter A; Honnen WJ; Revesz K; Herz R
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1341-4. PubMed ID: 1466953
    [No Abstract]   [Full Text] [Related]  

  • 39. Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.
    Mealey RH; Sharif A; Ellis SA; Littke MH; Leib SR; McGuire TC
    Virology; 2005 Aug; 339(1):110-26. PubMed ID: 15979679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of monoclonal antibodies against infections laryngotracheitis virus.
    Abbas F; Andreasen JR; Baker RJ; Mattson DE; Guy JS
    Avian Dis; 1996; 40(1):49-55. PubMed ID: 8713047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.